CDIO
Cardio Diagnostics Holdings Inc
NASDAQ: CDIO · HEALTHCARE · BIOTECHNOLOGY
$1.70
-1.16% today
Updated 2026-04-29
Market cap
$5.39M
P/E ratio
—
P/S ratio
363.32x
EPS (TTM)
$-3.71
Dividend yield
—
52W range
$1 – $14
Volume
4.2M
Cardio Diagnostics Holdings Inc (CDIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $25859.00 | $-585291.00 | $-5.09M | $-5.67M | $-4.99M | $-5.73M |
| Capital expenditures | $29910.00 | $114029.00 | $2.00 | $794291.00 | $404190.00 | $187317.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $589263.00 | $60000.00 | $4000.00 | $1.28M | $2.59M | $110235.00 |
| Free cash flow | $-4051.00 | $-699320.00 | $-5.09M | $-6.47M | $-5.40M | $-5.91M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |